AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an ...

Researchers from Nantong University developed a novel targeted drug delivery system using functionalized pillararenes for ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...

Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates.

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies ... AdvanCell to rapidly develop and progress novel Pb-212-containing radiotherapeutics from ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...

Neuropsychiatric disorders are becoming increasingly prevalent. Given their complex and multifactorial pathogenesis, there is ...

In a pioneering collaboration with AbbVie, Northwestern researchers have discovered a new way to potentially treat cancer by ...

Endoscopic ultrasound-guided radiofrequency ablation can offer an effective alternative to traditional surgery in treating ...